Harm Scholten

Dr. Harm Scholten


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
WHWalid Habre
Walid Habre
NDNicola Disma
Nicola Disma
KVKatalin Virag
Katalin Virag
KBKarin Becke
Karin Becke
MJMartin Jöhr
Martin Jöhr
PHPierre Harlet
Pierre Harlet

1 November 2005 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
PDF file
MTM.F. Termaat
M.F. Termaat
PRP.G.H.M. Raijmakers
P.G.H.M. Raijmakers
HSHarm Scholten
Harm Scholten
FBF.C. Bakker
F.C. Bakker
PPP. Patka
P. Patka
HHH.J.T.M. Haarman
H.J.T.M. Haarman
Background: A variety of diagnostic imaging techniques is available for excluding or confirming chronic osteomyelitis. Until now, an evidence-based algorithmic model for choosing the most suitable imaging technique has been lacking. The objective of this study was to determine the accuracy of current imaging modalities in the diagnosis of chronic osteomyelitis. Methods: A systematic review and meta-analysis of the literature was conducted with a comprehensive search of the MEDLINE, EMBASE, and Current Contents databases to identify clinical studies on chronic osteomyelitis that evaluated diagnostic imaging modalities. The value of each imaging technique was studied by determining its sensitivity and specificity compared with the results of histological analysis, findings on culture, and clinical follow-up of more than six months. Results: A total of twenty-three clinical studies in which the accuracy was described for radiography (two studies), magnetic resonance imaging (five), computed tomography (one), bone scintigraphy (seven), leukocyte scintigraphy (thirteen), gallium scintigraphy (one), combined bone and leukocyte scintigraphy (six), combined bone and gallium scintigraphy (three), and fluorodeoxyglucose positron emission tomography (four) were included in the review. No meta-analysis was performed with respect to computed tomography, gallium scintigraphy, and radiography. Pooled sensitivity demonstrated that fluorodeoxyglucose positron emission tomography was the most sensitive technique, with a sensitivity of 96% (95% confidence interval, 88% to 99%) compared with 82% (95% confidence interval, 70% to 89%) for bone scintigraphy, 61% (95% confidence interval, 43% to 76%) for leukocyte scintigraphy, 78% (95% confidence interval, 72% to 83%) for combined bone and leukocyte scintigraphy, and 84% (95% confidence interval, 69% to 92%) for magnetic resonance imaging. Pooled specificity demonstrated that bone scintigraphy had the lowest specificity, with a specificity of 25% (95% confidence interval, 16% to 36%) compared with 60% (95% confidence interval, 38% to 78%) for magnetic resonance imaging, 77% (95% confidence interval, 63% to 87%) for leukocyte scintigraphy, 84% (95% confidence interval, 75% to 90%) for combined bone and leukocyte scintigraphy, and 91% (95% confidence interval, 81% to 95%) for fluorodeoxyglucose positron emission tomography. The sensitivity of leukocyte scintigraphy in detecting chronic osteomyelitis in the peripheral skeleton was 84% (95% confidence interval, 72% to 91%) compared with 21% (95% confidence interval, 11% to 38%) for its detection of chronic osteomyelitis in the axial skeleton. The specificity of leukocyte scintigraphy in the axial skeleton was 60% (95% confidence interval, 39% to 78%) compared with 80% (95% confidence interval, 61% to 91%) for the peripheral skeleton. Conclusions: Fluorodeoxyglucose positron emission tomography has the highest diagnostic accuracy for confirming or excluding the diagnosis of chronic osteomyelitis. Leukocyte scintigraphy has an appropriate diagnostic accuracy in the peripheral skeleton, but fluorodeoxyglucose positron emission tomography is superior for detecting chronic osteomyelitis in the axial skeleton. Level of Evidence: Diagnostic Level III. See Instructions to Authors for a complete description of levels of evidence.

22 May 2017 in Anaesthesia
Verified
Journal Article
Closed access
PDF file
HSHarm Scholten
Harm Scholten
APA. Pourtaherian
A. Pourtaherian
NMN. Mihajlovic
N. Mihajlovic
HKH. H. M. Korsten
H. H. M. Korsten
RBR. A. Bouwman
R. A. Bouwman

24 November 2009 in European Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
JTJ. Tichelaar
J. Tichelaar
MRM. C. Richir
M. C. Richir
HAH. J. Avis
H. J. Avis
HSHarm Scholten
Harm Scholten
NAN. F. Antonini
N. F. Antonini
TVTh. P. G. M. De Vries
Th. P. G. M. De Vries
Purpose Although the importance of rational prescribing is generally accepted, the teaching of pharmacotherapy to undergraduate medical students is still unsatisfactory. Because clinical teachers are an important role model for medical students, it is of interest to know whether this extends to therapeutic decision-making. The aim of this study was to find out which factors contribute to the drug choices made by medical students and their teachers (general practitioners and clinical specialists). Methods Final-year medical students (n = 32), and general practitioners (n = 29), lung specialists (n = 26), orthopaedic surgeons (n = 24), and internists (n = 24) serving as medical teachers from all eight medical schools in the Netherlands participated in the study. They were asked to prescribe treatment (drug or otherwise) for uncomplicated (A) and complicated (B) written patient cases and to indicate which factors influenced their choice of treatment, using a list of factors reported in the literature to influence drug prescribing. Results Final-year medical students primarily based their drug choice on the factors ‘effectiveness of the drugs’ and ‘examples from medical teachers’. In contrast, clinical teachers primarily based their drug choice on the factors ‘clinical experience’, ‘effectiveness of the drugs’, ‘side effects of the drugs’, ‘standard treatment guidelines’, and ‘scientific literature’. Conclusions Medical teachers would appear to base their drug choice mainly on clinical experience and drug-related factors, whereas final-year medical students base their drug choice mainly on examples provided by their medical teachers. It is essential that medical teachers clearly explain to their students how they arrive at a specific choice of medication since medical students tend to copy the therapeutic drug choices from their teachers, mainly because of a lack of experience. Presenting students with clinical therapeutic problems early during undergraduate training will not only give them a chance to gain experience in solving medical problems but will also give meaning to what they are studying as opposed to merely reproducing what they learn or copying what they are told.

7 April 2017 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
APArash Pourtaherian
Arash Pourtaherian
HSHarm Scholten
Harm Scholten
LKLieneke Kusters
Lieneke Kusters
SZSvitlana Zinger
Svitlana Zinger
NMNenad Mihajlovic
Nenad Mihajlovic
FZFei Zou
Fei Zou
Ultrasound-guided medical interventions are broadly applied in diagnostics and therapy, e.g. regional anesthesia or ablation. A guided intervention using 2D ultrasound is challenging due to the poor instrument visibility, limited field of view and the multi-fold coordination of the medical instrument and ultrasound plane. Recent 3D ultrasound transducers can improve the quality of the image-guided intervention if an automated detection of the needle is used. In this paper, we present a novel method for detecting medical instruments in 3D ultrasound data that is solely based on image processing techniques and validated on various ex-vivo and in-vivo datasets. In the proposed procedure, the physician is placing the 3D transducer at the desired position and the image processing will automatically detect the best instrument view, so that the physician can entirely focus on the intervention. Our method is based on classification of instrument voxels using volumetric structure directions and robust approximation of the primary tool axis. A novel normalization method is proposed for the shape and intensity consistency of instruments to improve the detection. Moreover, a novel 3D Gabor wavelet transformation is introduced and optimally designed for revealing the instrument voxels in the volume, while remaining generic to several medical instruments and transducer types. Experiments on diverse datasets including in-vivo data from patients show that for a given transducer and instrument type, high detection accuracies are achieved with position errors smaller than the instrument diameter in the 0.5 to 1.5 millimeter range on average.

27 July 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
KRKoen P Rovers
Koen P Rovers
RLRobin J Lurvink
Robin J Lurvink
EWEmma Ce Wassenaar
Emma Ce Wassenaar
TKThomas Jm Kootstra
Thomas Jm Kootstra
HSHarm Scholten
Harm Scholten
IHIgnace de Hingh
Ignace de Hingh
Introduction: Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (ePIPAC-OX) is offered as a palliative treatment option for patients with isolated unresectable colorectal peritoneal metastases (PM) in several centres worldwide. However, little is known about its feasibility, safety, tolerability, efficacy, costs and pharmacokinetics in this setting. This study aims to explore these parameters in patients with isolated unresectable colorectal PM who receive repetitive ePIPAC-OX as a palliative monotherapy. Methods and analysis: This multicentre, open-label, single-arm, phase II study is performed in two Dutch tertiary referral hospitals for the surgical treatment of colorectal PM. Eligible patients are adults who have histologically or cytologically proven isolated unresectable PM of a colorectal or appendiceal carcinoma, a good performance status, adequate organ functions and no symptoms of gastrointestinal obstruction. Instead of standard palliative treatment, enrolled patients receive laparoscopy-controlled ePIPAC-OX (92 mg/m2 body surface area (BSA)) with intravenous leucovorin (20 mg/m2 BSA) and bolus 5-fluorouracil (400 mg/m2 BSA) every 6 weeks. Four weeks after each procedure, patients undergo clinical, radiological and biochemical evaluation. ePIPAC-OX is repeated until disease progression, after which standard palliative treatment is (re)considered. The primary outcome is the number of patients with major toxicity (grade ≥3 according to the Common Terminology Criteria for Adverse Events v4.0) up to 4 weeks after the last ePIPAC-OX. Secondary outcomes are the environmental safety of ePIPAC-OX, procedure-related characteristics, minor toxicity, postoperative complications, hospital stay, readmissions, quality of life, costs, pharmacokinetics of oxaliplatin, progression-free survival, overall survival, and the radiological, histopathological, cytological, biochemical and macroscopic tumour response. Ethics and dissemination: This study is approved by an ethics committee, the Dutch competent authority and the institutional review boards of both study centres. Results are intended for publication in peer-reviewed medical journals and for presentation to patients, healthcare professionals and other stakeholders. Trial registration number: NCT03246321, Pre-results; ISRCTN89947480, Pre-results; NTR6603, Pre-results; EudraCT: 2017-000927-29, Pre-results.